Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial

Overview of attention for article published in Journal of Clinical Immunology, September 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy: 1 policy source

patent: 1 patent

Citations

dimensions_citation: 157 Dimensions

Readers on

mendeley: 79 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseases

Grant US-9457084-B2

United States of America